Viewing Study NCT04957160

Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug

Ignite Creation Date: 2025-12-25 @ 2:16 AM

Ignite Modification Date: 2025-12-27 @ 11:04 PM

Study NCT ID: NCT04957160

Status: COMPLETED

Last Update Posted: 2024-12-17

First Post: 2021-01-12

Is NOT Gene Therapy: True

Has Adverse Events: False

Brief Title: Cabozantinib Post First-line Immuno-oncology Checkpoint Inhibitor Containing Combination

Sponsor: Ipsen

Organization:

Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module